BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator


8/17/2011 11:08:37 AM

SAN ANTONIO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Former Congressman and PhRMA CEO Billy Tauzin has joined the board of the pharmaceutical benefits management company CaptureRx. He will also serve as the company's Chief Industry Relations Officer.

Tauzin will work on behalf of CaptureRx, its hospital and health-center clients, and the national pharmacy networks that partner with the company. He will add his voice to initiatives that include identifying best practices and standardization of processes and reporting, and building relationships with managed care and federal and state agencies.

"Both clients of CaptureRx, a valued corporate member of our association, and the entire 340B community will be lifted by having someone of Mr. Tauzin's stature in our corner," said William von Oehsen, president of the Safety-net Hospitals for Pharmaceutical Access, the 340B trade association that represents more than 600 university and nonprofit hospital systems.

In 2004, Tauzin was diagnosed with a rare form of intestinal cancer. "I was given less than a 1 percent chance of survival, but thanks to innovative drug therapies, I overcame the odds," he said. "I see my new role with CaptureRx as an opportunity to increase the access that underinsured folks have to these life-saving pharmaceuticals,"said Tauzin, who served as Chief Executive Officer of the Pharmaceutical Research and Manufacturers for 5-1/2 years after leaving Congress.

Based in San Antonio, Texas, CaptureRx is a leader in administering a federal drug program called 340B, which lowers the cost of health care at zero cost to the government. Under the program, qualified hospitals and health centers purchase drugs for the program's patients at half the cost -- even less than Canadian drug prices.

This creates a safety net for much of the nation's under-insured and uninsured in an environment of looming federal deficits. The pharmaceutical industry provides the nearly $7 billion in annual funding for 340B via special pricing under federal regulation.

As CEO of PhRMA, Tauzin helped create the Partnership for Prescription Assistance (PPA), which provides free medicines to more than 6 million Americans who otherwise couldn't afford them. He will continue that push at CaptureRx by maintaining an open dialogue with drug manufacturers on compliance with the 340B program and the need to protect it.

CaptureRx manages one of the largest 340B programs in the country and operates the nation's largest 340B contracted pharmacy network. The company is a pioneer and technology leader in 340B processing and automation through its "cloud" based platform called Cumulus. To learn more, visit www.CaptureRx.com.

SOURCE CaptureRx



Read at BioSpace.com

PhRMA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES